The crypto market is buzzing with renewed optimism as Bloomberg’s Eric Balchunas declared that multiple spot crypto ETF approvals are now a certainty rather than a probability. Recent SEC changes have eliminated old approval timelines, paving the way for funds tied to Litecoin (LTC), Solana (SOL), and XRP to debut imminently. With ETFs historically driving […]The crypto market is buzzing with renewed optimism as Bloomberg’s Eric Balchunas declared that multiple spot crypto ETF approvals are now a certainty rather than a probability. Recent SEC changes have eliminated old approval timelines, paving the way for funds tied to Litecoin (LTC), Solana (SOL), and XRP to debut imminently. With ETFs historically driving […]

4 Coins Heating Up as Odds of Litecoin, Solana, and XRP ETF Approval Hit 100%

4 min read

The crypto market is buzzing with renewed optimism as Bloomberg’s Eric Balchunas declared that multiple spot crypto ETF approvals are now a certainty rather than a probability. Recent SEC changes have eliminated old approval timelines, paving the way for funds tied to Litecoin (LTC), Solana (SOL), and XRP to debut imminently. With ETFs historically driving institutional inflows, traders are seeking tokens that can capitalize on the wave of optimism. Besides the big names, other initiatives are heating up.  Little Pepe (LILPEPE), Sui (SUI), Hedera (HBAR), and NEAR Protocol (NEAR) are attracting investors due to their strong fundamentals, presale success, and network adoption. Here’s why these four stand out in the current ETF-fueled rally.

  1. Little Pepe (LILPEPE): Meme Coin With Utility Ready for 20x

While ETFs are pushing institutional coins forward, meme tokens remain the playground of retail investors. Little Pepe (LILPEPE) has successfully combined meme energy with genuine blockchain utility. Built on its own Ethereum-compatible Layer 2 chain, LILPEPE offers ultra-fast, low-cost transactions and a dedicated meme Launchpad designed to incubate new projects. The presale has been a resounding success. Now in Stage 13 of 19, priced at $0.0022, it has raised $26,659,397 with more than 16.2 billion tokens sold. Early participants from Stage 1 are already up 120%, while new buyers still have a potential 36% upside before the listing price of $0.0030.

What sets Little Pepe apart is its strong tokenomics:

  • 30% reserves to sustain long-term growth.
  • 13.5% for staking rewards to incentivize holders.
  • Zero buy/sell tax and sniper bot protection.

A CertiK audit, transparent listings on CoinMarketCap, and massive community giveaways, including a $777,000 prize pool and 15-ETH mega giveaway, have further fueled momentum. With over 42,000 holders and 37,000 Telegram members, LILPEPE is proving it’s more than hype. Analysts suggest that it could replicate the early growth of DOGE and SHIB, delivering potential returns in 2025.

  1. Sui (SUI): High-Performance Layer 1 in the Spotlight

Sui (SUI) has quickly gained traction as a next-gen Layer 1 blockchain built for speed and scalability. With a market cap of $12.99 billion and trading at $3.58, Sui has established itself as a serious competitor to Ethereum and Solana in powering decentralized apps. ETF optimism indirectly benefits Layer 1s like Sui, as institutional adoption fuels demand for scalable platforms. Developers are increasingly turning to Sui for its parallel transaction execution, which allows unprecedented throughput. If ETF-driven inflows lift overall crypto liquidity, Sui could be one of the biggest beneficiaries.

  1. Hedera (HBAR): Enterprise Adoption on the Rise

Hedera (HBAR) continues to stand out for its enterprise focus. Currently trading at $0.2254 with a market cap of $9.55 billion, Hedera’s unique hashgraph consensus technology enables faster and more energy-efficient transactions compared to traditional blockchains. Global enterprises, including Google, IBM, and Boeing, are part of its governing council, a sign of institutional confidence. As ETFs open the floodgates for broader adoption, HBAR’s reputation as an enterprise-grade crypto could see stronger demand. With analysts forecasting wider corporate blockchain use in 2025, Hedera is well-positioned for growth.

  1. NEAR Protocol (NEAR): Developer-Friendly and Expanding

NEAR Protocol (NEAR) has carved out a niche as a developer-friendly Layer 1. Priced at $3.03 with a market cap of $3.79 billion, NEAR has gained momentum through its user-centric design and chain abstraction technology, which simplifies dApp interactions for everyday users. ETF approvals for major tokens like XRP and Solana could act as a rising tide, lifting NEAR as investors diversify into emerging smart contract platforms. NEAR’s partnerships and expanding developer ecosystem make it a solid candidate for significant appreciation in the coming bull cycle.

Conclusion

The certainty of spot ETF approvals for Litecoin, Solana, and XRP is reshaping crypto market dynamics. While these big names attract institutional inflows, tokens like Little Pepe, Sui, Hedera, and NEAR are emerging as some of the most promising bets for outsized returns. Among them, Little Pepe (LILPEPE) stands out for combining meme energy with tangible blockchain innovation. For investors who missed early DOGE or SHIB runs, LILPEPE offers a rare second chance at entry before listings push it mainstream.

For more information about Little Pepe (LILPEPE) visit the links below:

Website: https://littlepepe.com

Whitepaper: https://littlepepe.com/whitepaper.pdf

Telegram: https://t.me/littlepepetoken

Twitter/X: https://x.com/littlepepetoken

Market Opportunity
4 Logo
4 Price(4)
$0.01189
$0.01189$0.01189
-3.33%
USD
4 (4) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29